Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Triamcinolone for Alopecia Areata
NCT01898806Phase 4Terminated
- Sponsor
- Columbia University
- Start
- Sep 2011
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of triamcinolone in alopecia areata (4 arms), sponsored by Columbia University. Primary endpoint: Proportion of Responders at 48 weeks. Started Sep 2011; status: terminated.
02
Drugs
triamcinolone
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT01898806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898806.